Literature DB >> 10497191

Killer cell immunoglobulin receptors and T cell receptors bind peptide-major histocompatibility complex class I with distinct thermodynamic and kinetic properties.

K Maenaka1, T Juji, T Nakayama, J R Wyer, G F Gao, T Maenaka, N R Zaccai, A Kikuchi, T Yabe, K Tokunaga, K Tadokoro, D I Stuart, E Y Jones, P A van der Merwe.   

Abstract

Human natural killer cells and a subset of T cells express a repertoire of killer cell immunoglobulin receptors (KIRs) that recognize major histocompatibility complex (MHC) class I molecules. KIRs and T cell receptors (TCRs) bind in a peptide-dependent manner to overlapping regions of peptide-MHC class I complexes. KIRs with two immunoglobulin domains (KIR2Ds) recognize distinct subsets of HLA-C alleles. Here we use surface plasmon resonance to study the binding of soluble forms of KIR2DL1 and KIR2DL3 to several peptide-HLA-Cw7 complexes. KIR2DL3 bound to the HLA-Cw7 allele presenting the peptide RYRPGTVAL with a 1:1 stoichiometry and an affinity (K(d) approximately 7 microM at 25 degrees C) within the range of values measured for other cell-cell recognition molecules, including the TCR. Although KIR2DL1 is reported not to recognize the HLA-Cw7 allele in functional assays, it bound RYRPGTVAL/HLA-Cw7, albeit with a 10-20-fold lower affinity. TCR/peptide-MHC interactions are characterized by comparatively slow kinetics and unfavorable entropic changes (Willcox, B. E., Gao, G. F., Wyer, J. R. , Ladbury, J. E., Bell, J. I., Jakobsen, B. K., and van der Merwe, P. A. (1999) Immunity 10, 357-365), suggesting that binding is accompanied by conformational adjustments. In contrast, we show that KIR2DL3 binds RYRPGTVAL/HLA-Cw7 with fast kinetics and a favorable binding entropy, consistent with rigid body association. These results indicate that KIR/peptide-MHC class I interactions have properties typical of other cell-cell recognition molecules, and they highlight the unusual nature of TCR/peptide-MHC recognition.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10497191     DOI: 10.1074/jbc.274.40.28329

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Human herpesvirus 8 K14 protein mimics CD200 in down-regulating macrophage activation through CD200 receptor.

Authors:  Mildred Foster-Cuevas; Gavin J Wright; Michael J Puklavec; Marion H Brown; A Neil Barclay
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

Review 2.  Innate immune control of HIV.

Authors:  Mary Carrington; Galit Alter
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

3.  Peptide antagonism as a mechanism for NK cell activation.

Authors:  Lena Fadda; Gwenoline Borhis; Parvin Ahmed; Kuldeep Cheent; Sophie V Pageon; Angelica Cazaly; Stavros Stathopoulos; Derek Middleton; Arend Mulder; Frans H J Claas; Tim Elliott; Daniel M Davis; Marco A Purbhoo; Salim I Khakoo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-03       Impact factor: 11.205

4.  Molecular basis for LLT1 protein recognition by human CD161 protein (NKRP1A/KLRB1).

Authors:  Jun Kamishikiryo; Hideo Fukuhara; Yuki Okabe; Kimiko Kuroki; Katsumi Maenaka
Journal:  J Biol Chem       Date:  2011-05-13       Impact factor: 5.157

5.  Molecular mechanism of the recognition of bacterially cleaved immunoglobulin by the immune regulatory receptor LILRA2.

Authors:  Rika Yamazaki; Atsushi Furukawa; Kouyuki Hirayasu; Kohei Yumoto; Hideo Fukuhara; Hisashi Arase; Katsumi Maenaka
Journal:  J Biol Chem       Date:  2020-05-18       Impact factor: 5.157

6.  Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors.

Authors:  C Andrew Stewart; Fanny Laugier-Anfossi; Frédéric Vély; Xavier Saulquin; Jenifer Riedmuller; Agnès Tisserant; Laurent Gauthier; François Romagné; Géraldine Ferracci; Fernando A Arosa; Alessandro Moretta; Peter D Sun; Sophie Ugolini; Eric Vivier
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-02       Impact factor: 11.205

7.  Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G.

Authors:  Mitsunori Shiroishi; Kouhei Tsumoto; Kimie Amano; Yasuo Shirakihara; Marco Colonna; Veronique M Braud; David S J Allan; Azure Makadzange; Sarah Rowland-Jones; Benjamin Willcox; E Yvonne Jones; P Anton van der Merwe; Izumi Kumagai; Katsumi Maenaka
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-09       Impact factor: 11.205

Review 8.  Natural killer cells and cancer: regulation by the killer cell Ig-like receptors (KIR).

Authors:  Amanda K Purdy; Kerry S Campbell
Journal:  Cancer Biol Ther       Date:  2009-12-28       Impact factor: 4.742

9.  Allelic variation in KIR2DL3 generates a KIR2DL2-like receptor with increased binding to its HLA-C ligand.

Authors:  William R Frazier; Noriko Steiner; Lihua Hou; Sivanesan Dakshanamurthy; Carolyn Katovich Hurley
Journal:  J Immunol       Date:  2013-05-17       Impact factor: 5.422

10.  Ligand-independent exhaustion of killer immunoglobulin-like receptor-positive CD8+ T cells in human immunodeficiency virus type 1 infection.

Authors:  Galit Alter; Suzannah Rihn; Hendrik Streeck; Nickolas Teigen; Alicja Piechocka-Trocha; Kristin Moss; Kristen Cohen; Angela Meier; Florencia Pereyra; Bruce Walker; Marcus Altfeld
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.